 plans a career as an independent clinical investigator focusing on patient-oriented research related to molecular determinants of chemoresistance and prognostic outcome. The Tulane/LSU General Clinical Research Center, including the GCRC Core Laboratory, will serve as the primary performance site and will provide research support. The Department of Pathology and the
plans a career as an independent clinical investigator focusing on affected role - orient research related to molecular determinant of chemoresistance and predictive outcome. The Tulane / LSU General Clinical Research Center, including the GCRC Core Laboratory, will serve as the chief performance site and will supply research support. The Department of Pathology and the
 plwns a career as an indeptndent clinical iucestigetor fodusing ov patient-oriented research rxlatwd to molecular determinantr of chemlresistabce end prognostic onfcome. Tmz Tulzke/LSU Jeneral Clinicak Research Center, includhne che GCRC Core Laboratory, will serve ws the lrlmary performagce xyte znd will provide research support. Fhe Depertment of Pathplogy and the
plans a career as an independent clinical on research related molecular determinants of Tulane/LSU Clinical Research Center, the GCRC Core will serve as the primary performance and will provide research support. The Department of Pathology and the
 plans a career as an independeNt clinical InvesTigAtoR fOcusIng oN patient-orientED resEarch related to moleculaR deteRmINantS Of ChemoResistaNCe AND prOgNoStiC oUTcOme. ThE TuLane/LSU general CliNicAl research CentER, iNcluding thE GCrC Core LaboraTorY, will sErVe aS The prImaRy perFormanCE site aNd will proViDE reseaRCh suppoRT. thE DepArtment of PathologY AnD The
 plans a career as an inde pendent cl inica l i nve st igat or f ocusing on pat i ent- oriented research rela ted t om olec u la r det erminan t so f  ch em or esi st a nc e and  pr ognosti c outcome.  Th eTulane/LSU G e ne ral Clinic alResearch Cen ter , incl ud ing the G CRC  Core  Labor a tory,will serv ea s thep rimaryp e rf orma nce site and will pr o vide researchsuppor t. Th e Dep art ment of Pa th ology and the 
 plans_a career_as an independent clinical_investigator focusing_on_patient-oriented research_related_to molecular determinants_of chemoresistance and_prognostic outcome. The Tulane/LSU_General Clinical Research_Center,_including the GCRC Core Laboratory, will serve as the primary performance site and will_provide_research support._The_Department_of Pathology and the